LONDON--(BUSINESS WIRE)--Technavio has announced the top five leading vendors in their recent global bovine respiratory disease treatment market report until 2021. This research report also lists seven other prominent vendors that are expected to impact the market during the forecast period.
The research study by Technavio on the global bovine respiratory disease treatment market for 2017-2021 provides a detailed industry analysis based on product (antibiotics and vaccines) and geography (the Americas, EMEA, and APAC).
“The global bovine respiratory disease treatment market is projected to grow to almost USD 1,277 million by 2021, at a CAGR of more than 8% over the forecast period. The development of novel products is leading to new opportunities, resulting in the growth of the market,” says Sapna Jha, a lead analyst at Technavio for infectious and rare diseases research.
Competitive vendor landscape
The global BRD treatment market is characterized by key vendors such as Merck, Bayer HealthCare, Zoetis, Boehringer Ingelheim, and Elanco. The development of novel therapeutics such as DNA immunostimulants is expected to increase the competition in the market. Vendors in the market compete based on pricing, novel therapeutics, and advancements in technology. Players in the market who successfully improve their production and manufacturing expertise to provide antibiotics and vaccines that have high efficacy and safety will flourish in the competitive market space.
Looking for more research on this report? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Top five vendors in the global bovine respiratory disease treatment market
Bayer HealthCare
Bayer HealthCare focuses on the R&D, production, and sales of drugs, pharmaceuticals, vaccines, antibiotics, and small components for human and animal health worldwide. Its key products include Baytril, Zelnate, and Loncor 300.
Boehringer Ingelheim
Boehringer Ingelheim undertakes the research, development, manufacture, and marketing of human and animal products. The company leverages its key drugs, Pyramid, Presponse, Bovalto Respi, ZACTRAN, and RELIANT PLUS BVD-K to generate substantial revenue.
Elanco
Elanco undertakes the manufacturing and distribution of feed supplements and drugs for disease and nutrition management. The company has a state-of-the-art Vaccines Innovation Center that allows researchers to address some of the animal health’s most unmet needs.
Merck
Merck undertakes the R&D, manufacture, and marketing of prescription medicines, biologic therapies, vaccines, and animal health products. Merck Animal Health launched the BOVILIS CORONAVIRUS, a first modified live intranasal vaccine to facilitate the reduction of enteric disease caused by Bovine Coronavirus.
Zoetis
Zoetis undertakes the discovery, development, manufacture, and commercialization of a wide portfolio of animal health medicines and vaccines. The company offers a one-dose vial of Rispoval IntraNasal to offer respiratory health protection in calves after birth.
Browse Related Reports:
- Global Factor IX Deficiency Treatment Market 2017-2021
- Global Factor VIII Deficiency Treatment Market 2017-2021
- Infectious Disease Treatment Market in China 2016-2020
Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like cardiovascular devices, central nervous system, and in-vitro diagnostics. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.
About Technavio
Technavio is leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users.
If you are interested in more information, please contact our media team at media@technavio.com.
